Evaluation of apoptosis in peripheral blood lymphocytes of renal transplant patients

被引:6
作者
Carpio, V. N. [1 ]
Aquino-Dias, E. C. [1 ]
Prochnow, T. A. [1 ]
Manfro, R. C. [1 ]
Goncalves, L. F. S. [1 ]
机构
[1] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Sch Med, Potsgrad Nephrol Program,Div Nefrol,Unidade Trans, BR-90035003 Porto Alegre, RS, Brazil
关键词
CELL-DEATH; T-CELLS; ACTIVATION; RECIPIENTS;
D O I
10.1016/j.transproceed.2006.06.082
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
The aim of this study was to evaluate the occurrence of apoptosis and the expression of FasL and IL-2 genes in apoptotic peripheral blood mononuclear cells (PBMC) at different posttransplant periods. Three groups of patients were studied: group 1, kidney transplant recipients at least 1 year posttransplant (n = 17); group 2, kidney transplant recipients at least 5 years posttransplant (n = 15); and a control group composed of 7 healthy subjects. Apoptosis was detected by annexin flow cytometry and gene expression by reverse transcription polymerase chain reactions. The percentage of apoptotic cells was significantly higher in groups 1 (42 +/- 4%) and 2 (37 +/- 3%) than the controls (27 +/- 2%; P <.0001). Apoptotic cells in group 1 was significantly higher than in group 2 (P <.005). A significant difference in FasL expression was observed between groups 1 and 2 (P <.001) and the immunosuppressive regimen. These findings suggest that PBMC of kidney transplant recipients are more susceptible to activation-induced cell death and that the Fas-FasL pathway is involved in this process.
引用
收藏
页码:1898 / 1900
页数:3
相关论文
共 7 条
[1]
Activation-induced T cell death, and aberrant T cell activation via TNFR1 and CD95-CD95 ligand pathway in stable cardiac transplant recipients [J].
Ankersmit, HJ ;
Moser, B ;
Zuckermann, A ;
Roth, G ;
Taghavi, S ;
Brunner, M ;
Wolner, E ;
Boltz-Nitulescu, G .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 128 (01) :175-180
[2]
Enhanced apoptosis of peripheral blood mononuclear cells in cardiac transplanted patients undergoing chronic immunosuppressive treatment [J].
Di Renzo, M ;
Capecchi, PL ;
Camurri, A ;
Di Ciolla, F ;
Maccherini, M ;
Lisi, G ;
Pompella, G ;
Pasqui, AL ;
Auteri, A ;
Abbracchio, MP ;
Pasini, FL .
TRANSPLANT IMMUNOLOGY, 2002, 10 (04) :269-275
[3]
Molecular markers in subclinical acute rejection of renal transplants [J].
Dias, ECA ;
Veronese, FJV ;
Gonçalves, LFS ;
Manfro, RC .
CLINICAL TRANSPLANTATION, 2004, 18 (03) :281-287
[4]
Regulation of activation-induced cell death of mature T-lymphocyte populations [J].
Janssen, O ;
Sanzenbacher, R ;
Kabelitz, D .
CELL AND TISSUE RESEARCH, 2000, 301 (01) :85-99
[5]
Expression of FasL gene in T cells of renal allograft recipients [J].
Kasprzycka, M ;
Klodos, K ;
Nowaczyk, M ;
Wyzgal, J ;
Podobinska, I ;
Durlik, M ;
Górski, A .
IMMUNOLOGY LETTERS, 2002, 80 (01) :9-13
[6]
T-cell apoptosis following renal transplantation [J].
Kasprzycka, M ;
Górski, A ;
Nowaczyk, M ;
Korczak-Kowalska, G ;
Wierzbicki, P ;
Durlik, M ;
Wyzgal, J ;
Gradowska, L ;
Lao, M .
TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) :2353-2354
[7]
Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs [J].
Strauss, G ;
Osen, W ;
Debatin, KM .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 128 (02) :255-266